Novartis Sounds Alarm Bell On Global Trade Policy

 
• By Mary Jo Laffler
  
US tariffs on pharmaceuticals are part of the problem, Novartis says (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Drug Pricing

More from Business